Bridgeway Capital Management, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.76 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$1.01 - $1.82 $202,000 - $364,000
-200,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.27 - $3.42 $254,000 - $684,000
200,000 New
200,000 $394,000
Q2 2019

Aug 14, 2019
SELL
$6.6 - $7.8 $97,680 - $115,440
-14,800 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$5.26 - $7.97 $662,312 - $1 Million
-125,915 Reduced 89.48%
14,800 $86,000
Q3 2018

Nov 13, 2018
BUY
$4.65 - $7.95 $654,324 - $1.12 Million
140,715 New
140,715 $1.06 Million

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $5.67B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email